Business
PAR Receives US Ethics Approval for Phase 3
PAR Receives US Ethics Approval for Phase 3
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":250,"tagName":"div"}]